Company Search:
Advanced Search
Sponsored Links
TG Therapeutics Inc Company Snapshot
TG Therapeutics Inc operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares TG Therapeutics Inc with three other companies in this sector in UNITED STATES : Palatin Technologies, Inc. (2020 sales of $117,989.00 of which 100% was Licenses, Grants and Contracts), Lumos Pharma Inc ($168,000.00 of which 100% was biopharmaceutical segment), and Viracta Therapeutics Inc ($120,000.00 of which 100% was Pharmaceuticals).

Sales Analysis. Sales were up sharply during the second quarter of 2021 versus the previous year's second quarter. During the second quarter of 2021, sales at TG Therapeutics Inc totalled $1.55 million. This is an increase of 3,965.8% from the $38,000.00 in sales at the company during the second quarter of 2020. This was the biggest same quarter rise in sales at TG Therapeutics Inc in the previous 32 quarters. During the first two quarters of 2021, sales totalled $2.34 million, which is 2,976.3% higher than through the first two quarters of 2020. TG Therapeutics Inc reported sales of $152,000.00 for the year ending December of 2020. This represents a very small increase of 0.0% versus 2019, when the company's sales were $152,000.00 . The sales level in 2020 was fairly close to the level five years ago: in 2015, TG Therapeutics Inc had sales of $152,381.00 .
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
TG Therapeutics Inc
  Stock Performance Chart for TG Therapeutics Inc
  Stock Data: Recent Stock Performance:
  Current Price (10/22/2021): 31.40
(Figures in U.S. Dollars)
1 Week -5.7%   13 Weeks -2.4%  
4 Weeks -17.0%   52 Weeks 16.3%  
TG Therapeutics Inc Key Data:
  Ticker: TGTX Country: United States
  Exchanges: OTC Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2020 Sales 152,000
(Year Ending Jan 2021).
Employees: 272
  Currency: U.S. Dollars Market Cap: 4,484,940,060
  Fiscal Yr Ends: December Shares Outstanding: 142,832,486
  Share Type: Common Closely Held Shares: 9,273,666
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.